Dysbiosis and zonulin upregulation alter gut epithelial and vascular barriers in patients with ankylosing spondylitis
The mean duration of semaglutide treatment was 28 months
semaglutide, n =21), weight and BMI were 90.5 kg (83.4, 107.9) and 34.0 kg/m 2 (31.7, 38.7), respectively, with a post-bariatric weight regain of 15.1% (10.6, 22.8) of total body weight and 4.6 kg/m 2 (3.3, 6.2)
35 Underlying Conditions: Certain conditions, notably type 2 diabetes, are associated with slightly less weight loss on these medications compared to individuals without diabetes
We strive to set the standard for quality, safety and value in the discovery, development, and manufacture of health care products, including innovative medicines and vaccines
Most weight loss specialists avoid this combination due to overlapping cardiovascular effects and limited safety data supporting concurrent use